Nanomaterial-driven spatiotemporal autophagy modulation: The dual-edged sword in precision cancer therapy
Authors:
Open Access
- 29 June 2026
- journal article
- review article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (9) , 5814-5846
Abstract
No abstract availableKeywords
Funding Information
- Macau University of Science and Technology
- Hebei Province Science and Technology Support Program
- National Natural Science Foundation of China
This publication has 394 references indexed in Scilit:
- PSMA‐Targeted Nanoparticles with PI3K/mTOR Dual Inhibitor Downregulate P‐Glycoprotein and Inactivate Myeloid‐Derived Suppressor Cells for Enhanced Chemotherapy and Immunotherapy in Prostate CancerAdvanced Materials, 2025
- Recent Advances in Nanomaterial‐Mediated Cell Death for Cancer TherapyAdvanced Healthcare Materials, 2024
- CDK4/6 Inhibitors Impede Chemoresistance and Inhibit Tumor Growth of Small Cell Lung CancerAdvanced Science, 2024
- Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent FerroptosisAdvanced Science, 2024
- Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome‐lysosome Fusion in NSCLCAdvanced Science, 2024
- Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy (Adv. Mater. 22/2023)Advanced Materials, 2023
- A Bimetallic Metal–Organic‐Framework‐Based Biomimetic Nanoplatform Enhances Anti‐Leukemia Immunity via Synchronizing DNA Demethylation and RNA HypermethylationAdvanced Materials, 2023
- Aggregation‐Induced Emission (AIE) and Magnetic Resonance Imaging Characteristics for Targeted and Image‐Guided siRNA Therapy of Hepatocellular CarcinomaAdvanced Healthcare Materials, 2022
- pH‐Sensitive Molecular‐Switch‐Containing Polymer Nanoparticle for Breast Cancer Therapy with Ferritinophagy‐Cascade Ferroptosis and Tumor Immune ActivationAdvanced Healthcare Materials, 2021
- Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate CancerJAMA Oncology, 2018